This would give an idea on the value of the company and what it is trying to achieve. Back in January, Lumiradx was to be acquired by a big player in the diagnostics industry Roche. 318Million shares outstanding and a purchase price of $295Million. Annual revenue 2023 of $125MillionUSD.
Roche Purchase
If Febridx and Viradx can produce reasonable revenues over the next few quarters coupled with FFN testing etc, I cant see why they couldn't achieve similar levels.
- Forums
- ASX - By Stock
- LDX
- Ann: Lumos Receives US$400k Phase 1 Milestone from Hologic
Ann: Lumos Receives US$400k Phase 1 Milestone from Hologic, page-17
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LDX (ASX) to my watchlist
|
|||||
Last
4.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.17M |
Open | High | Low | Value | Volume |
4.3¢ | 4.4¢ | 4.3¢ | $52.03K | 1.191M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 376799 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 345568 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 371799 | 0.043 |
4 | 639826 | 0.042 |
2 | 292500 | 0.041 |
2 | 280001 | 0.040 |
1 | 360000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 345568 | 4 |
0.046 | 600000 | 2 |
0.048 | 218015 | 3 |
0.049 | 200000 | 1 |
0.050 | 200000 | 1 |
Last trade - 15.29pm 12/07/2024 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |